{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:20:26Z","timestamp":1790522426696,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organization for Health Research and Development","doi-asserted-by":"crossref","award":["918.19.627"],"award-info":[{"award-number":["918.19.627"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003180","name":"Academic Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003180","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.cmi.2019.04.032","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:43:30Z","timestamp":1557834210000},"page":"199-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Resurgence of pneumococcal meningitis in Europe and Northern America"],"prefix":"10.1016","volume":"26","author":[{"given":"D.L.H.","family":"Koelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"van de Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.04.032_bib1","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1038\/nrdp.2016.74","article-title":"Community-acquired bacterial meningitis","volume":"2","author":"van de Beek","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cmi.2019.04.032_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(12)61187-8","article-title":"Effect of vaccines on bacterial meningitis worldwide","volume":"380","author":"McIntyre","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.04.032_bib3","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cmi.2019.04.032_bib4","first-page":"19","article-title":"Recommended childhood immunization schedule\u2014United States, 2001","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2019.04.032_bib5","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein\u2013polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.04.032_bib6","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/165-Supplement_1-S49","article-title":"Thymus-independent and thymus-dependent responses to polysaccharide antigens","volume":"165","author":"Stein","year":"1992","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/515644","article-title":"Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults","volume":"178","author":"Rubins","year":"1998","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.rmed.2004.04.012","article-title":"Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids","volume":"98","author":"de Roux","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.cmi.2019.04.032_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QCO.0000000000000182","article-title":"The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria","volume":"28","author":"Perez","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib10","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998\u20132007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.04.032_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-016-0755-7","article-title":"Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis","volume":"14","author":"Alari","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.cmi.2019.04.032_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1473-3099(14)70805-9","article-title":"Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study","volume":"14","author":"Castelblanco","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1473-3099(18)30349-9","article-title":"Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey","volume":"18","author":"Ouldali","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","article-title":"Community-acquired bacterial meningitis in adults in The Netherlands, 2006\u201314: a prospective cohort study","volume":"16","author":"Bijlsma","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/JCM.01917-12","article-title":"Changes in molecular epidemiology of Streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales","volume":"51","author":"Pichon","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2019.04.032_bib17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/INF.0b013e31817bd2dc","article-title":"Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine","volume":"27","author":"Casado-Flores","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2019.04.032_bib18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1183\/13993003.01451-2015","article-title":"Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden","volume":"47","author":"Galanis","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.04.032_bib19","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1016\/j.vaccine.2014.07.060","article-title":"Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study","volume":"32","author":"Meichtry","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.04.032_bib20","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1016\/j.vaccine.2012.03.060","article-title":"Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme","volume":"30","author":"Ingels","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.04.032_bib21","first-page":"179","article-title":"Epidemiology of bacterial meningitis in the North American arctic, 2000\u20132010","volume":"71","author":"Gounder","year":"2015","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.04.032_bib22","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pneumococcal serotypes in children in 4 European countries","volume":"16","author":"Hanquet","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib23","first-page":"134","article-title":"Invasive pneumococcal disease in children and adults in seven Italian regions after the introduction of the conjugate vaccine, 2008\u20132014","volume":"39","author":"D'Ancona","year":"2015","journal-title":"Epidemiol Prev"},{"key":"10.1016\/j.cmi.2019.04.032_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/1403494815581695","article-title":"Clinical burden of pneumonia, meningitis and septicemia in Norway 2 years after 7-valent pneumococcal conjugate vaccine introduction","volume":"43","author":"Munson","year":"2015","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.cmi.2019.04.032_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12879-015-0787-1","article-title":"Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany","volume":"15","author":"Imohl","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/INF.0b013e31805cdbeb","article-title":"Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005","volume":"26","author":"Messina","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2019.04.032_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":"Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine","volume":"26","author":"Pelton","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2019.04.032_bib28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1473-3099(18)30346-3","article-title":"Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?","volume":"18","author":"Desmet","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015080","article-title":"Bacterial meningitis in Finland, 1995\u20132014: a population-based observational study","volume":"7","author":"Polkowska","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2019.04.032_bib30","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1016\/j.vaccine.2017.09.050","article-title":"Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States","volume":"35","author":"Jacobs","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.04.032_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib34","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","article-title":"ESCMID guideline: diagnosis and treatment of acute bacterial meningitis","volume":"22","author":"van de Beek","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.032_bib35","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.cmi.2016.07.026","article-title":"Impact of an evidence-based guideline on the management of community-acquired bacterial meningitis: a prospective cohort study","volume":"22","author":"Costerus","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.032_bib36","doi-asserted-by":"crossref","first-page":"21057","DOI":"10.2807\/1560-7917.ES2015.20.10.21057","article-title":"Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012","volume":"20","author":"Weiss","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2019.04.032_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/infdis\/jis703","article-title":"Pneumococcal capsular switching: a historical perspective","volume":"207","author":"Wyres","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/cid\/ciw357","article-title":"Clinical and epidemiological evidence of the red queen hypothesis in pneumococal serotype dynamics","volume":"63","author":"Stockmann","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.tim.2011.06.001","article-title":"Risk of red queen dynamics in pneumococcal vaccine strategy","volume":"19","author":"Jefferies","year":"2011","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.cmi.2019.04.032_bib40","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3201\/eid2411.170817","article-title":"Emergence of Neisseria meningitidis serogroup W, Central African Republic, 2015\u20132016","volume":"24","author":"Frank","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib41","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2018058","article-title":"Emergence of Neisseria meningitidis W135 in Cote d'Ivoire: laboratory based-surveillance","volume":"40","author":"Soumahoro","year":"2018","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.cmi.2019.04.032_bib42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/21645515.2018.1532248","article-title":"Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies","volume":"15","author":"Booy","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2019.04.032_bib43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine","volume":"46","author":"Munoz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/590002","article-title":"Changing epidemiology of invasive pneumococcal disease: a complicated story","volume":"47","author":"Black","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.04.032_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30660-1","article-title":"Making sense of differences in pneumococcal serotype replacement","author":"Lewnard","year":"2019","journal-title":"The Lancet InfectDis"},{"key":"10.1016\/j.cmi.2019.04.032_bib46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-0691.2009.02726.x","article-title":"Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae","volume":"15","author":"Dagan","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.032_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cmi.2019.04.032_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14712598.2018.1384462","article-title":"Development of pneumococcal vaccines over the last 10 years","volume":"18","author":"Principi","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.cmi.2019.04.032_bib49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.vaccine.2014.11.011","article-title":"Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012","volume":"33","author":"Lepoutre","year":"2015","journal-title":"Vaccine"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19302101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19302101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:24:57Z","timestamp":1761117897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19302101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1198743X19302101"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.04.032","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resurgence of pneumococcal meningitis in Europe and Northern America","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.04.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}